TDO2 and Neoplasm of the liver: On the other hand, neither DEN treatment nor IDO genotype altered the expression levels of TDO mRNA, a hepatic enzyme that catalyzes the first step of tryptophan degradation, in either liver tumors or non-tumorous liver (Fig 6C).